1 Clinical success |
29 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
1.1 Diclofenac |
10 |
2050 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.60 [1.49, 1.72] |
1.2 Ibuprofen |
5 |
436 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.64 [1.33, 2.01] |
1.3 Ketoprofen |
7 |
683 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.56 [1.37, 1.77] |
1.4 Piroxicam |
3 |
504 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.48 [1.27, 1.73] |
1.5 Indomethacin |
3 |
341 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.26 [1.03, 1.55] |
1.6 Benzydamine |
3 |
193 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.15 [0.96, 1.38] |
2 Local adverse events |
33 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
2.1 Diclofenac |
15 |
3271 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.78 [0.56, 1.10] |
2.2 Ibuprofen |
3 |
321 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.30 [0.98, 5.43] |
2.3 Ketoprofen |
8 |
852 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.19 [0.83, 1.70] |
2.4 Piroxicam |
3 |
522 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.42 [0.17, 1.08] |
2.5 Felbinac |
3 |
397 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.91 [0.49, 7.50] |
2.6 Indomethacin |
3 |
354 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.65 [0.91, 7.73] |